Hu, Yun
Paris, Sébastien
Bertolet, Genevieve
Barsoumian, Hampartsoum B.
He, Kewen
Sezen, Duygu
Chen, Dawei
Wasley, Mark
SILVA, Jordan DA
Mitchell, Joylise A.
Voss, Tiffany A.
Masrorpour, Fatemeh
Leyton, Claudia Kettlun
Yang, Liangpeng
Leuschner, Carola
Puebla-Osorio, Nahum
Gandhi, Saumil
Nguyen, Quynh-Nhu
Cortez, Maria Angelica
Welsh, James W.
Article History
Received: 5 May 2022
Accepted: 26 August 2022
First Online: 19 September 2022
Declarations
:
: All animal procedures were approved by the Institutional Animal Care and Use Committee at MD Anderson Cancer Center.
: We understand that the text and any pictures published in the article will be freely available on the internet and may be seen by the general public. The pictures and text may also appear on other websites or in print, may be translated into other languages or used for commercial purposes.
: James W. Welsh (JWW) reports research support from GlaxoSmithKline, Bristol Meyers Squibb, Merck, Nanobiotix, RefleXion, Alkermes, Artidis, Mavu Pharma, Takeda, Varian, and Checkmate Pharmaceuticals. JWW serves on the scientific advisory board for Legion Healthcare Partners, RefleXion Medical, MolecularMatch, Merck, AstraZeneca, Aileron Therapeutics, OncoResponse, Checkmate Pharmaceuticals, Mavu Pharma, Alpine Immune Sciences, Ventana Medical Systems, Nanobiotix, China Medical Tribune, GI Innovation, Genentech and Nanorobotics. JWW is on Speaking Engagements for Ventana Medical Systems, US Oncology, Alkermes, and Boehringer Ingelheim. He is co-founder of Healios, MolecularMatch, OncoResponse and serves as an advisor to Astra Zeneca, OncoResponse, Merck, MolecularMatch, Incyte, Aileron and Nanobiotix. JWW holds stock or ownership in Alpine Immune Sciences, Checkmate Pharmaceuticals, Healios, Mavu Pharma, Legion Healthcare Partners, MolecularMatch, Nanorobotics, OncoResponse, and RefleXion. JWW has accepted honoraria in the form of travel costs from Nanobiotix, RefleXion, Varian, Shandong University, The Korea Society of Radiology, Aileron Therapeutics and Ventana. JWW has the following patents; MP470 (amuvatinib), MRX34 regulation of PDL1, XRT technique to overcome immune resistance. MD Anderson Cancer Center has a trademark for RadScopalTM. The rest of the authors disclosed no competing interests. Sebastien Paris and Jordan DA SILVA are employees of Nanobiotix.